Lilly in Richmond, Virginia

In September 2025, we announced the first of four new sites to join our U.S. manufacturing network in 2025, the Goochland County, Virginia facility, will make cancer, autoimmune and other advanced therapies. The $5 billion site will be our first dedicated active pharmaceutical ingredient plant to support bioconjugate and large molecule medicines.

Lilly in Goochland County, Virginia, USA
LillyVA_Thumbnail_Square
Working to help people live healthier requires investing in the future of medicine making. That’s why we’re excited to share the details of the first in Virginia’s Goochland County, just outside of Richmond.